Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Poolbeg Pharma Ltd. ( (GB:POLB) ) is now available.
Poolbeg Pharma has announced the release of its Annual Report and Accounts for the period ending December 31, 2024, along with the notice for its Annual General Meeting (AGM) scheduled for June 23, 2025. The company has also issued a Circular detailing a fundraising initiative, which will be sent to shareholders. These documents are available on the company’s website. This announcement underscores Poolbeg Pharma’s ongoing efforts to engage shareholders and secure funding, which could impact its operational capabilities and market position.
More about Poolbeg Pharma Ltd.
Poolbeg Pharma plc is a clinical-stage biopharmaceutical company focused on developing innovative medicines to address unmet medical needs. The company’s clinical programs target large addressable markets, including cancer immunotherapy-induced Cytokine Release Syndrome (CRS) and metabolic conditions such as obesity, with the development of an oral encapsulated glucagon-like peptide GLP-1R agonist.
Average Trading Volume: 1,003,463
Technical Sentiment Signal: Sell
For detailed information about POLB stock, go to TipRanks’ Stock Analysis page.